Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells-Reference-Cited by-同舟云学术

Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells

Published:2022-01 Issue:1 Volume:15 Page:101265
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Saha Nayanendu,Xu Kai,Zhu Zhongyu,Robev Dorothea,Kalidindi Teja,Xu Yan,Himanen Juha,de Stanchina Elisa,Pillarsetty Naga Vara Kishore,Dimitrov Dimiter S,Nikolov Dimitar B

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. The ADAMS: signalling scissors in the tumour microenvironment;Murphy;Nat. Rev. Cancer,2008

2. ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets;Dreymueller;Am. J. Physiol.-Lung Cell. Mol. Physiol.,2015

3. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer;Pruessmeyer;Semin. Cell Dev. Biol.,2009

4. The ADAMs family of metalloproteases: multidomain proteins with multiple functions;Seals;Genes Dev.,2003

5. Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans;Janes;Cell,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy;Nature Communications;2024-01-04

2. Association of disintegrin-metalloproteinase 33 gene polymorphisms with cholangiocarcinoma and serum tumor marker levels;World Chinese Journal of Digestology;2023-10-28

3. Emerging Immunotherapy Approaches for Treating Prostate Cancer;International Journal of Molecular Sciences;2023-09-20

4. Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells;Biomedicine & Pharmacotherapy;2023-05

5. A structural model of the iRhom–ADAM17 sheddase complex reveals functional insights into its trafficking and activity;Cellular and Molecular Life Sciences;2023-04-29